← Payloads & linkersC[C@@H]1[C@@H]2C[C@]([C@@H](/C=C/C=C(/CC3=CC(=C(C(=C3)OC)Cl)N(C(=O)C[C@@H]([C@]4(C1O4)C)OC(=O)[C@H](C)NC)C)\C)OC)(NC(=O)O2)O
Physicochemistry
Properties
Bioactivity
ADCdb (DRG0JCWGF): Phase 1 objective response rate 22.70% (all). Preclinical xenograft tumor growth inhibition approximately 51% to 100% across cell lines. No payload IC50 reported on ADCdb/PubChem pages.
1 agent
ADCs built on this payload
Agent · target
Ocular
Hepatic
Neutrop.
Thrombo.
Anemia
GI
ILD
Neuro.
TRPH-222CD22